文献速递医学教育与科研方法临床试验与 GCP

意大利研究机构对主要研究者试验注册知识及数据透明度的审计

An audit to evaluate an institute's lead researchers' knowledge of trial registries and to investigate adherence to data transparency issues in an Italian research institute registry.
PubMed 文献 · Trials · 2018-09-20

该研究通过问卷审计评估IRCCS Mario Negri米兰分部主要研究者对试验注册的认知及机构注册库数据质量。覆盖12项RCT,发现研究者对注册目的有基本了解,但机构注册库中92%记录至少缺一项数据,且注册时机与结果报告存在不足。作者建议定期自我审计以提升试验披露透明度。

要点

  • 多数研究者知晓ClinicalTrials.gov,但仅少数了解WHO ICTRP平台。
  • 机构注册库中92%的RCT记录至少缺失一个数据项。
  • 研究者常未在机构注册库填写国际注册的试验ID。

核心结论

  • 研究者应确保正确报告试验及其数据,机构应定期自我审计以改善临床试验披露。

研究设计与样本

  • 基于问卷的审计,样本覆盖IRCCS Mario Negri米兰分部47项RCT中的12项,代表所有负责RCT的主要研究者。

主要发现

  • 所有研究者报告知晓ClinicalTrials.gov且多数频繁使用,但仅少数了解WHO国际临床试验注册平台。
  • 最常提及的注册目的是增加透明度和减少发表偏倚。
  • 机构注册库中92%的研究记录至少缺一个数据项。
  • 12名受访者均称其试验已注册并说明注册库名称,但常未在机构注册库相应字段填入试验ID。
  • 11名研究者称试验在开始招募前注册;6项已结题试验中5项结果已发表,其中1项在完成后1年内发表。

临床怎么用

  • 机构应定期开展自我审计以发现并改善临床 trial 披露中的不足。
  • 研究者需在机构注册库中完整填写数据,包括国际注册的试验ID。
  • 应加强研究者对WHO ICTRP等注册平台的认知。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Clinical trial registries have been a priority topic in the past few years in promoting data transparency and accountability. In this context, in 2011, the IRCCS - Istituto di Ricerche Farmacologiche "Mario Negri" set up a registry to collect data on all studies in which the institute's researchers are involved. In this study we present a self-audit in order to detect the lead researchers' general knowledge on registries, the completeness and quality of the randomized controlled trial (RCT) data inputted in an Italian research institute's registry, and the researchers' adherence to both registration requirements and the institute transparency goal, aiming to improve standards and leading to greater awareness of the issues involved. METHODS: A questionnaire-based audit was conducted. To interview researchers we included questions ranging from general knowledge on registries (e.g., what are the aims of registries?) to questions about their knowledge of the Mario Negri's registry, questions on selected trials and registration, included information on the protocol, and the results. RESULTS: The audit sample covers 12 of the 47 RCTs at the institute's Milan branch, representing all the possible lead researchers responsible for RCTs at the institute. The researchers have more than a basic knowledge of trial registries and their aims. All the researchers reported that they know of the ClinicalTrials.gov registry and most of them reported that they frequently use it; however, only a few know about the World Health Organization's registry platform (International Clinical Trials Registry Platform). The most cited registry aims reported were increased transparency and reduced publication bias. Of the studies registered in the institute's registry, 92% had at least one data item missing in the registry record. Concerning trial registration in the international registries, all 12 respondents said their trial had been registered and specified the registry name, but often they had not inputted the associated trial ID code in the corresponding field of the institute's registry. Concerning two important issues on data transparency and ethical standards, namely registration timing and result reporting, 11 stated that their trial was registered before starting recruitment, and for five of six closed trials they stated that their results have been already published-for one trial within 1 year after its completion. CONCLUSIONS: Researchers should guarantee correct reporting of trials and their data as a rule of great ethical value. Institutional self-audits should be performed periodically in order to improve clinical trial disclosure.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Pandolfini C, Bonati M. An audit to evaluate an institute's lead researchers' knowledge of trial registries and to investigate adherence to data transparency issues in an Italian research institute registry. Trials. 2018. PMID: 30236146. doi:10.1186/s13063-018-2910-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。